Grow your business safely with ALMA BIO THERAPEUTICS

All the information you need about ALMA BIO THERAPEUTICS to develop and secure your business in France

A HOME > CORPORATES > ALMA BIO THERAPEUTICS > BALANCE SHEET ( 2018-01-17)

THE LIST OF BALANCE SHEET : ALMA BIO THERAPEUTICS

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2021-11-04 Public 2020-12-31 Complete
2021-01-05 Public 2019-12-31 Complete
2019-12-16 Public 2018-12-31 Complete
2018-12-11 Public 2017-12-31 Complete
2018-01-17 Public 2016-12-31 Complete
NameALMA BIO THERAPEUTICS
Siren798709309
Closing2016-12-31
Registry code 6901
Registration number B2018/001430
Management number2013B06068
Activity code 7490B
Closing date n-12015-12-31
Duration Fiscal year 12
Duration Fiscal year n-112
Filing date2018-01-17
Modification01 Annual accounts entered with accounting inconsistencies at document source
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPublic
Address69007 LYON
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
AF Concessions, Patents and Similar Rights 158 851.00 46 409.00 112 441.00 158 851.00
AT Other tangible assets 2 629.00 1 942.00 687.00 2 629.00
BH Other financial assets 8 025.00 8 025.00 8 025.00
BJ TOTAL (I) 1 178 890.00 67 269.00 1 111 621.00 1 178 890.00
BZ Other receivables 107 873.00 107 873.00 107 873.00
CF Cash and cash equivalents 163 643.00 163 643.00 163 643.00
CH Prepaid expenses 7 051.00 7 051.00 7 051.00
CJ TOTAL (II) 278 567.00 278 567.00 278 567.00
CO Grand total (0 to V) 1 457 456.00 67 269.00 1 390 187.00 1 457 456.00
CX Development or Research and Development Expenses 1 009 385.00 18 917.00 990 468.00 1 009 385.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
DA Share or individual capital 26 750.00 22 460.00 26 750.00
DB Share, merger, contribution premiums, etc. 1 138 567.00 869 355.00 1 138 567.00
DH Retained earnings -460 131.00 -301 332.00 -460 131.00
DI RESULTS FOR THE YEAR (Profit or Loss) -194 341.00 -158 799.00 -194 341.00
DL TOTAL (I) 510 845.00 431 684.00 510 845.00
DN Conditional advances 496 443.00 326 443.00 496 443.00
DO TOTAL (II) 496 443.00 326 443.00 496 443.00
DU Loans and Debts from Credit Institutions (3) 959.00 959.00
DV Miscellaneous Loans and Financial Debts (4) 113 068.00 113 068.00
DX Trade payables and related accounts 252 466.00 113 218.00 252 466.00
DY Tax and social security liabilities 16 406.00 9 497.00 16 406.00
EC TOTAL (IV) 382 899.00 122 714.00 382 899.00
EE Grand total (I to V) 1 390 187.00 880 841.00 1 390 187.00
EI Including equity loans 110 000.00 110 000.00
3 - Income statementAmount France year NAmount Export year NTotal year NTotal year N-1
FO Operating subsidies 107 100.00
FQ Other income 363 564.00
FR Total operating income (I) 470 664.00
FW Other purchases and external expenses 550 320.00
FX Taxes, duties, and similar payments 1 310.00
FY Salaries and Wages 92 310.00
FZ Social Security Contributions 16 863.00
GB Operating Expenses - Provisions 22 900.00
GE Other Expenses 9.00
GF Total Operating Expenses (II) 683 712.00
GG - OPERATING RESULT (I - II) -213 048.00
GP Total financial income (V) 210.00
GU Total financial expenses (VI) 5 338.00
GV - FINANCIAL INCOME (V - VI) -5 128.00
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) -218 177.00
4 - Income statement (continued)Amount year NAmount year N-1
HD Total exceptional income (VII) 266.00 361.00 266.00
HI - EXCEPTIONAL RESULT (VII - VIII) 266.00 361.00 266.00
HK Income tax -23 570.00 -72 972.00 -23 570.00
HL TOTAL REVENUE (I + III + V + VII) 471 140.00 341 109.00 471 140.00
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) 665 480.00 499 908.00 665 480.00
HN PROFIT OR LOSS (Total revenue - Total expenses) -194 341.00 -158 799.00 -194 341.00
5 - Fixed assets increase - decreaseGross value at beginning of year - Item by itemRevaluation - DisposalsAcquisition - Gross value at year-end
0G ACQUISITIONS Total General Total 785 258.00 785 258.00
CZ ACQUISITIONS: Establishment, Development, or Research Expenses 648 519.00 648 519.00
I3 DECREASES Total Financial Fixed Assets 8 025.00
I4 DECREASES Grand Total 1 178 890.00
IN DECREASES Start-up, development, or research expenses 1 009 385.00
IO DECREASES Total including other intangible assets 158 851.00
IY DECREASES Total Tangible Fixed Assets 2 629.00
KD ACQUISITIONS Total including other intangible assets 126 986.00 126 986.00
LN ACQUISITIONS Total Tangible Fixed Assets 1 728.00 1 728.00
LQ ACQUISITIONS Total Financial Fixed Assets 8 025.00 8 025.00
6 - Depreciation Amount at beginning of yearIncrease: allocation for the yearDiminution repriseYear-end amount
0N DEPRECIATION Grand Total 45 435.00 23 776.00 45 435.00
CY DEPRECIATION Start-up, development, or research expenses 18 917.00 18 917.00
PE DEPRECIATION Total including other intangible assets 24 385.00 22 024.00 24 385.00
QU DEPRECIATION Total Tangible Fixed Assets 2 132.00 1 752.00 2 132.00
8 - Receivables and payablesGross amountAmount within 1 yearAmount 1 to 5 yearsAmount more than 5 years
8A Miscellaneous Loans and Financial Debts 110 000.00 44 000.00 110 000.00
8B Suppliers and Related Accounts 252 466.00 252 466.00 252 466.00
8K Other liabilities (including liabilities related to repo transactions) 3 068.00 3 068.00 3 068.00
UT Other financial assets 8 025.00 8 025.00
UX Other trade receivables 107 873.00 107 873.00
VH Loans with a maturity of more than one year at origin 959.00 959.00 959.00
VS Prepaid expenses 7 051.00 7 051.00
VT TOTAL – STATEMENT OF RECEIVABLES 122 948.00 114 923.00 8 025.00 122 948.00
VY TOTAL – STATEMENT OF LIABILITIES 382 899.00 272 899.00 44 000.00 382 899.00

all companies in France

Complete and comprehensive database.